Intraoperative mannitol during robotic-assisted-laparoscopic partial nephrectomy

Area of Science:

• Urology
• Nephrology
• Surgical Innovation

Background:

• Mannitol is traditionally used for renoprotection during partial nephrectomies.
• Minimally invasive techniques, like robotic-assisted laparoscopic partial nephrectomy (RALPN), may alter the necessity of mannitol.
• Reduced warm ischemia time in RALPN might diminish mannitol's protective effects.

Purpose of the Study:

• To evaluate the efficacy of intraoperative mannitol in preserving renal function after RALPN.
• To determine if mannitol provides a statistically significant benefit for post-operative renal function outcomes in RALPN.
• To challenge the routine use of mannitol in robotic partial nephrectomy procedures.

Main Methods:

• A prospective, randomized, double-blinded, controlled study was conducted.
• Patients undergoing RALPN were randomized to receive either mannitol or normal saline.
• Renal function was assessed by estimated glomerular filtration rate (eGFR) preoperatively and at 24 hours, 1 week, and 30 days postoperatively.

Main Results:

• No statistically significant differences in preoperative eGFR were observed between the mannitol and saline groups.
• The median percent change in eGFR after surgery showed no statistical difference between the groups.
• Intraoperative mannitol infusion did not significantly improve or maintain renal function post-RALPN.

Conclusions:

• Routine intraoperative mannitol administration does not provide significant renal function benefits following robotic-assisted laparoscopic partial nephrectomy.
• The findings suggest that mannitol can be discontinued in RALPN procedures.
• This study provides evidence to guide practice changes in perioperative care for RALPN.